NOVOSTENT COMPLETES SECOND CLOSE RAISING A TOTAL OF $12.75 MILLION IN NEW FINANCING

NovoStent Corporation, a medical device company that has developed a novel "anchored" helical stent technology to provide a wide range of vascular therapies, announced today a final closing of its second round of financing, raising an additional $3.1 million for a total of $12.75 million. The Company closed on $9.65 million in May 2005. The financing was led by Sanderling Ventures, and included Montreux Equity Partners, Forward Ventures, Mitsui & Co. Venture Partners, The Band of Angels Fund and Peninsula Equity Partners.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1036513XSL_NEWSML_TO_NEWSML_WEB.xml)